Serum Bicarbonate and Mortality in Stage 3 and Stage 4 Chronic Kidney Disease
Sankar D. Navaneethan(Baylor College of Medicine), Joseph V. Nally(Cleveland Clinic), Jesse D. Schold(Colorado School of Public Health), Titte R. Srinivas(Intermountain Healthcare), James F. Simon(Cleveland Clinic), Susana Arrigain(Cleveland Clinic), Edgard Wehbe(Cleveland Clinic), Martin J. Schreiber(Cleveland Clinic), Anil Jain(Wythenshawe Hospital), Stacey E. Jolly(Cleveland Clinic), Rupesh Raina(Cleveland Clinic)
Cited by 181
Related Papers
Heart Disease and Stroke Statistics—2021 Update
|Circulation|2021|5.7k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study
|The Lancet Child & Adolescent Health|2017|722
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure
|JAMA|2016|696
Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
|The Lancet Diabetes & Endocrinology|2019|330